New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
allAfrica.com on MSN
Africa: Phase 2 Clinical Trial Results Show Potential to Shorten TB Treatment Time
Sorfequiline, previously known as TBAJ-876, was evaluated in combination with pretomanid and linezolid in a randomized, controlled trial in people with drug-sensitive TB ...
News-Medical.Net on MSN
New clinical trial shows promise for shorter TB treatment
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...
Much of the current antimicrobial resistance (AMR) crisis in India is driven by overuse of common antibiotics like ...
Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...
Delhi health minister Pankaj Kumar Singh claimed on Friday that there is no shortage of essential medicines in state govt-run ...
Copenhagen, Denmark Friday, November 14, 2025, 14:00 Hrs [IST] ...
Science Africa on MSN
TB Treatment Can be Shortened, Clinical Trial Shows
By Sharon Atieno With tuberculosis (TB) treatment lasting about six to nine months, a new treatment regimen is set to reduce this period.A phase two clinical trial by TB Alliance has showed that a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback